Armbruster Capital Management’s GSK GSK Stock Holding History

Armbruster Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-320	Closed	-$16K	–	123
2018 Q1	$16K	Hold	320	–	–	0.01%	173
2017 Q4	$14K	Hold	320	–	–	0.01%	189
2017 Q3	$16K	Hold	320	–	–	0.01%	179
2017 Q2	$17K	Hold	320	–	–	0.01%	180
2017 Q1	$17K	Sell	320 -46	-13%	-$2.33K	0.01%	183
2016 Q4	$18K	Hold	366	–	–	0.01%	183
2016 Q3	$20K	Hold	366	–	–	0.01%	177
2016 Q2	$20K	Sell	366 -16	-4%	-$843	0.01%	186
2016 Q1	$19K	Sell	382 -240	-39%	-$12K	0.01%	192
2015 Q4	$31K	Buy	+622	New	+$31.7K	0.03%	170

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Armbruster Capital Management's GSK Position: Q2 2018 in Review

Armbruster Capital Management sold out of GSK (GSK) in Q2 2018, closing a stake of 320 shares — an estimated $16K sold.

Armbruster Capital Management first reported a position in GSK in Q4 2015 and held it in 10 quarters. The position peaked at $31K in Q4 2015. 787 funds tracked by Wall St. Rank hold GSK as of Q2 2018.

Armbruster Capital Management reported no remaining GSK position as of Q2 2018 after selling out during the quarter.
Armbruster Capital Management sold 320 GSK shares in Q2 2018, an estimated $16K.
Armbruster Capital Management first reported a position in GSK in Q4 2015 and held it in 10 quarters.
Armbruster Capital Management's GSK position peaked at $31K in Q4 2015.
787 funds tracked by Wall St. Rank held GSK as of Q2 2018.

Based on Armbruster Capital Management's 13F filing for Q2 2018, filed 30 Jul 2018.